Media Coverage

Hospitals frequently license the research and development from their physicians to generate what can be substantial revenue.[CR-LF][CR-LF]Indeed, intellectual property is the bread and butter investment for many academic and nonprofit health systems, helping to bring in some return while allowing physicians, who often develop those innovations themselves, to retain some benefit. Earlier this year, Mayo Clinic said it has generated $600 million in revenue from licensing its IP since 1986.[CR-LF][CR-LF]The dispute between Cedars-Sinai and Quest Diagnostics involves a noninvasive blood test to detect IBS developed by Cedars-Sinai doctor Mark Pimentel.

Quest Diagnostics, the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, unveiled Quest Lab Stewardship powered by hc1, an innovative new service that employs machine learning to harmonise laboratory testing across health systems in order to help optimise laboratory test utilisation.[CR-LF][CR-LF]Quest Lab Stewardship is the result of a strategic collaboration between Quest and hc1 focused on improving costs and clinical impact of lab testing, in- and out- of hospital settings.

Delaware Health Information Network and Quest Diagnostics have been working together for some time, and the network now has extended Quest’s participation as a data provider in Delaware, submitting lab results and clinical data to DHIN. With the new agreement, Quest results will be available to healthcare practitioners statewide through DHIN delivery channels and the Community Health Record’s searchable patient catalog, with the goal to give doctors more actionable information to improve outcomes. Formed in 2007, the Delaware network now offers nearly 20 services.

Quest Diagnostics and hc1 developed a new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization. [CR-LF][CR-LF] Editor's Note: This article originally appeared on Quest Diagnostic's website. [CR-LF][CR-LF]Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.*

Quest Diagnostics and Hc1 are collaborating on a service called Quest Lab Stewardship, which will use Hc1's machine learning technology to help optimize laboratory test use. The technology will collect and analyze laboratory data to improve management of test usage and identify inappropriate or inefficient testing.